U.S. Software Stock News

NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Is It Too Late To Consider Coinbase Global (COIN) After Its Recent Share Price Rebound

This article considers whether Coinbase Global's recent share price suggests a potential bargain or already reflects its current story, by comparing its value against several common yardsticks. At a last close of US$192.96, the stock has returned 2.8% over the past week and 10.1% over the past month. It is down 18.4% year to date and has returned 219.7% over three years and 27.2% over five years. Recent headlines around Coinbase Global have focused on its role as a listed gateway to crypto...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Warner Music Group Extends Film Reach With Paramount As Valuation Gap Persists

Warner Music Group and Paramount Pictures have agreed a multi year, first look partnership to develop theatrical films based on Warner Music artists and songwriters. The deal focuses on creating new cinema projects that tap into both legendary and contemporary acts from Warner Music Group. This collaboration pairs a major recorded music company with a leading Hollywood studio to build film concepts around music IP. For investors watching NasdaqGS:WMG, this new film partnership sits...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Assessing Regeneron (REGN) After Recent Share Price Weakness And Strong Valuation Signals

If you are wondering whether Regeneron Pharmaceuticals at around US$709.10 is priced attractively or already reflects the story, the valuation picture is where the answers start to emerge. The stock is up 0.3% over the last 7 days, while it shows a 6.7% decline over 30 days, an 8.7% decline year to date, and a 30.2% return over the past year, which can change how investors think about both upside potential and risk. Recent headlines around Regeneron often focus on its position within large...
NYSE:DFIN
NYSE:DFINCapital Markets

Is Donnelley Financial Solutions (DFIN) Pricing Look Attractive After Recent Share Price Weakness

Wondering if Donnelley Financial Solutions at around US$44 is offering value or just noise? This article breaks down what the current price might actually mean for you. The stock recently closed at US$44.21, with returns of a 12.1% decline over 7 days, a 10.0% decline over 30 days and a 3.1% decline year to date, alongside a 17.2% decline over 1 year, a 0.2% decline over 3 years and a 73.6% gain over 5 years. Recent coverage of Donnelley Financial Solutions has focused on its role in...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Is It Time To Revisit DraftKings (DKNG) After Recent Share Price Rebound

If you are trying to work out whether DraftKings stock looks attractively priced or too expensive at today’s levels, you will want more than just the latest share price in front of you. The stock recently closed at US$25.22, with returns of 8.1% over 7 days and 9.9% over 30 days, while year to date and 1 year returns of negative 29.3% and negative 28.7% show a very different picture over a longer window. Recent headlines around DraftKings have largely focused on the broader US sports betting...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Is It Too Late To Consider Krystal Biotech (KRYS) After Its Strong Share Price Run?

For investors wondering if Krystal Biotech at around US$296.70 is still offering value or if the easy gains are behind it, this article walks through what the current price may be implying. The stock has shown strong share price moves, with returns of 13.1% over 7 days, 12.4% over 30 days, 20.2% year to date, 116.3% over the last year, 228.5% over 3 years, and 374.4% over 5 years. These price moves sit against a backdrop of ongoing attention on Krystal Biotech's position in the...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Gibraltar Industries (ROCK) Margin Compression And Q1 EPS Loss Test Bullish Growth Narrative

Gibraltar Industries (ROCK) opened Q1 2026 with total revenue of US$356.3 million and a basic EPS loss of US$0.40, setting a cautious tone around the latest numbers. The company has seen quarterly revenue move from US$246.4 million and EPS of US$0.76 in Q1 2025 through a series of US$309.5 million to US$310.9 million quarters with EPS between US$0.99 and US$1.12, before landing at US$268.7 million and EPS of US$0.40 in Q4 2025. This gives investors a clear look at how the top line has...
NYSE:MTG
NYSE:MTGDiversified Financial

How Investors Are Reacting To MGIC Investment (MTG) Q1 Revenue Dip With Stable EPS

MGIC Investment Corporation recently reported its first-quarter 2026 results, with revenue of US$297.08 million and net income of US$165.3 million, both lower than the same period a year earlier. Despite the revenue and profit declines, MGIC’s basic and diluted earnings per share from continuing operations held around US$0.76, indicating stable per-share profitability even as overall earnings softened. Now we’ll examine how this combination of lower revenue but steady earnings per share...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Is It Too Late To Consider Sigma Lithium (SGML) After Its Strong 1 Year Rally?

Wondering if Sigma Lithium's current share price reflects its true worth, or if the recent excitement has run ahead of the fundamentals? The stock last closed at US$23.65, with returns of 7.2% over 7 days, 61.7% over 30 days, 66.4% year to date, 218.7% over 1 year and 401.5% over 5 years, while the 3 year return stands at a loss of 40.0%. Recent coverage has focused on Sigma Lithium as a lithium producer, with investors watching how sentiment around the sector and the company's development...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Energy (ES) Earnings Surge And Margin Expansion Test Long Term Bearish Narratives

Eversource Energy (ES) opened 2026 with Q1 revenue of about US$4.5 billion and basic EPS of US$1.61, setting the stage against a year of sharply higher trailing earnings and wider margins. Over the last six reported quarters, quarterly revenue has ranged from US$2.8 billion to US$4.5 billion while basic EPS has moved between roughly US$0.20 and US$1.61, and on a trailing twelve month basis EPS reached US$4.69 alongside revenue of about US$13.9 billion. With trailing net margin sitting above...
NYSE:NABL
NYSE:NABLSoftware

N Able (NABL) Q1 Revenue Growth Tests Profitability Turnaround Narratives

N-able (NABL) has opened 2026 with Q1 revenue of US$133.7 million and a basic EPS loss of US$0.00, alongside net income excluding extraordinary items of a US$0.6 million loss, setting a mixed tone for the latest results. Over recent quarters the company has seen revenue move from US$118.2 million in Q1 2025 to US$133.7 million in Q1 2026, while basic EPS has shifted between a profit of US$0.01 in Q3 2025 and a larger loss of US$0.04 in Q4 2025 before this latest small loss per share. For...
NYSE:Q
NYSE:QSemiconductor

Is It Too Late To Consider Qnity Electronics (Q) After A 69% Year To Date Surge?

If you are wondering whether Qnity Electronics at around US$143.59 is richly priced or still offers value, this breakdown outlines what the current share price might be implying. The stock has returned 2.1% over the last 7 days, 20.7% over the past month, and 69.0% year to date, which has put valuation squarely on investors' radar. Recent coverage has focused on Qnity Electronics' position within the semiconductor sector and how investors are reassessing companies tied to data infrastructure...
NYSE:TKO
NYSE:TKOEntertainment

TKO Group Holdings (TKO) Margin Improvement Tests Bullish High Quality Earnings Narrative

TKO Group Holdings (TKO) opened 2026 with Q1 revenue of about US$1.6b and basic EPS of US$1.16, alongside trailing 12 month EPS of US$2.84 on revenue of roughly US$5.1b and net income of US$226.35m, setting a clear marker for how the business is currently earning. Over recent quarters, revenue has moved from US$927.92m in Q4 2024 to US$1.27b in Q1 2025 and then to US$1.60b in Q1 2026. Quarterly basic EPS has ranged from US$0.38 in Q4 2024 to US$0.72 in Q1 2025 and US$1.16 in Q1 2026, giving...
NYSE:YSS
NYSE:YSSAerospace & Defense

Is York Space Systems (YSS) Offering Value After Recent 30 Day Share Price Jump

If you are wondering whether York Space Systems is fairly priced or offering an opportunity at current levels, the next sections break down what the numbers suggest about value. The stock recently closed at US$33.38, with returns of 0.7% over the past week, 21.1% over the last 30 days, and a small year to date decline of 0.7%. This may catch the eye of investors watching for a turning point in sentiment. Recent attention around York Space Systems has focused on its position in the space and...
NYSE:CNP
NYSE:CNPIntegrated Utilities

Is CenterPoint Energy (CNP) Pricing Look Stretched After Recent Share Price Weakness

If you are wondering whether CenterPoint Energy at around US$42.24 is offering good value today, it helps to separate the story, the share price moves and what the numbers actually say. The stock has a 9.1% return year to date, 13.9% over 1 year and 96.0% over 5 years, even though the last 7 and 30 days show returns of 3.2% and 3.1% declines. This means recent moves may feel very different from the longer term picture. Recent coverage has focused on CenterPoint Energy as a regulated utility...
NasdaqGS:APP
NasdaqGS:APPSoftware

AppLovin (APP) Q1 Earnings Reinforce Bullish Narrative With 63.5% Net Margin

AppLovin (APP) has opened 2026 with Q1 revenue of US$1.8 billion and basic EPS of US$3.57, setting the tone for its latest earnings season update. The company has seen quarterly revenue move from US$1.0 billion in Q4 2024 to US$1.2 billion in Q1 2025 and then to US$1.8 billion in Q1 2026. Basic EPS over the same points stepped from US$1.76 to US$2.13 and then to US$3.57, giving investors a clear view of scaling revenue alongside higher earnings per share as margins stay in focus. See our full...
NasdaqGS:RXT
NasdaqGS:RXTIT

Rackspace Technology (RXT) Returns To Quarterly Profit Challenging Bearish Earnings Narratives

Rackspace Technology (RXT) opened 2026 with Q1 revenue of US$678.1 million and basic EPS of US$0.03, compared to a trailing 12 month basic EPS loss of US$0.60 on revenue of US$2.7 billion. The company has seen quarterly revenue move from US$685.6 million in Q4 2024 to US$665.4 million in Q1 2025 and US$678.1 million in Q1 2026. Basic EPS shifted from a loss of US$0.25 in Q4 2024 to a loss of US$0.31 in Q1 2025 and then to a small profit in the latest quarter. This sets up a results season...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion’s AI Drug Programs Show Early Clinical Progress And Valuation Gap

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical milestones across several AI-driven drug programs. REC-1245 showed encouraging early safety data in humans. Patient dosing has started for REC-4539, moving another asset into active clinical testing. REC-4881 produced meaningful efficacy signals in familial adenomatous polyposis, prompting engagement with the FDA about a potential registrational path. For investors watching NasdaqGS:RXRX, these program updates focus...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

Solstice Advanced Materials (SOLS) Q1 EPS Rebound Tests Bullish Growth Narratives

Solstice Advanced Materials (SOLS) opened 2026 with Q1 revenue of US$992 million and basic EPS of US$0.54, giving investors a fresh look at its earnings power after a volatile prior year. Over recent quarters the company has seen revenue move from US$897 million in Q1 2025 to US$969 million in Q3 2025, US$987 million in Q4 2025 and now US$992 million in Q1 2026. Quarterly basic EPS has ranged from a loss of US$0.22 in Q3 2025 to US$0.84 in Q1 2025 and US$0.26 in Q4 2025 before landing at...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Is It Too Late To Consider Nebius Group (NBIS) After Its Recent Share Price Surge?

Investors may naturally wonder whether Nebius Group at US$184.77 is now priced for perfection or still offers room for value after such a strong run. The stock has posted returns of 33.7% over the past week, 57.4% over the past month and 105.4% year to date, with a very large 1 year gain that may have shifted how investors view both its potential and its risks. Recent coverage has focused on Nebius Group's sharp share price moves and what they might imply about sentiment toward its business...
NYSE:STVN
NYSE:STVNLife Sciences

Stevanato Group (NYSE:STVN) Margin Uptick Tests Bullish Earnings Narrative After Q1 2026 Results

Stevanato Group (NYSE:STVN) opened 2026 with Q1 revenue of €273.6 million and basic EPS of €0.10, alongside trailing 12 month revenue of about €1.2 billion and EPS of €0.52 that frame the latest quarter against a fuller earnings backdrop. Over recent periods, revenue has ranged from €256.6 million in Q1 2025 to €346.5 million in Q4 2025, while basic EPS has moved between €0.10 and €0.17 across those quarters, giving investors a clear view of how the top and bottom lines are tracking into the...